Side-by-side financials for BVS and BSX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BVS | BSX |
|---|---|---|
| Market cap | - | $70.11 B |
| US-listed rank | - | #243 |
| Revenue (latest FY) | $568.09M | $20.07B |
| Net income (latest FY) | $22.73M | - |
| Net margin | 4.0% | - |
| SEC filings | 445 | 1,009 |
In their latest fiscal years, Bioventus Inc. reported $568.09M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: Bioventus Inc. and BOSTON SCIENTIFIC CORP, or browse the full rankings.